title: [Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?].
authors.forename: Lourdes
authors.initials: L
authors.lastname: Viñuela
authors.forename: Mónica
authors.initials: M
authors.lastname: de Frutos-Serna
authors.forename: María Luz
authors.initials: ML
authors.lastname: Asensio
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Muñoz-Bellido
authors.forename: José Elías
authors.initials: JE
authors.lastname: García-Sánchez
mesh_terms: D000328:Adult; D000892:Anti-Infective Agents, Urinary / Q000494:pharmacology / Q000627:therapeutic use*; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000382:microbiology; D017408:Guidelines as Topic; D006801:Humans; D008826:Microbial Sensitivity Tests; D013030:Spain; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000892:Anti-Infective Agents, Urinary